Related Experiment Video
Updated: Sep 26, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
2,4-disubstituted pyrimidines: a novel class of KDR kinase inhibitors
Peter J Manley1, Adrienne E Balitza, Mark T Bilodeau
1Departments of Medicinal Chemistry and Cancer Research, Merck Research Laboratories, 19486, West Point, PA, USA
Abstract:
2,4-Disubstituted pyrimidines were synthesized as a novel class of KDR kinase inhibitors. Evaluation of the SAR of the screening lead compound 1 (KDR IC(50)=105 nM, Cell IC(50)=8% inhibition at 500 nM) led to the potent 3,5-dimethylaniline derivative 2d (KDR IC(50)=6 nM, cell IC(50)=19 nM).
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Dipeptidyl Peptidase 4 Inhibitors
Antiviral Nucleoside Inhibitors
Receptor Tyrosine Kinases
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...